Antiviral Therapies in Pediatric Influenza: What Does the Current Data Say?

Activity Overview

In order to possess a working knowledge of the latest therapeutic advances and treatment strategies, clinicians need to stay up-to-date on the latest clinical data. This activity will consist of a 15-minute video-based presentation by one nationally recognized expert in the treatment of pediatric influenza focused on the latest clinical data and critical analysis of late-breaking clinical trial data in order to help clinicians stay current and provide optimal care for patients.

0.25 CE Credit(s)
Expires: December 8, 2023

Target Audience

Pediatricians, family practice, and primary care clinicians managing pediatric patients with influenza.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Differentiate between antiviral therapies for influenza prevention and treatment in young children according to their efficacy and safety
  • Personalize antiviral therapy for influenza prevention and treatment in pediatric patients

Activity Faculty

Charles P. Vega, MD, FAAFP

Charles P. Vega, MD, FAAFP

Assistant Dean, Culture and Community Education
School of Medicine
University of California – Irvine
Irvine, CA

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group. 

Considering Therapies for Influenza Treatment and Post-Exposure in Children

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources